Fiducial Markers Market

Fiducial Markers Market Size Survey Report – In a Glance

As per the survey report on the global Fiducial Markers Market, the market is projected to foresee a CAGR of 4.8% between 2024-2033, and further generate a market size of USD 409.2 million revenue by the end of 2033. In the year 2024, the market size was valued at USD 154.2 million revenue.

• The global Fiducial Markers Market is projected to grow on account of increasing cases of numerous kinds of cancer.
• In Japan, the improvement in cancer care and innovation, can be attributed to the growth in the Fiducial Markers Market.
• KDMI analyst’s growth analysis foresees shortage of skilled professionals to challenge market growth.
• North America, having the highest market share in the Fiducial Markers Market, is projected to dominate the global market.

Fiducial Markers Market Analysis

Fiducial markers are tiny medical objects positioned in the field of an image view for application as a point of measure or reference. It marks a zone for surgery or radiation treatment, for instance, small gold seeds are placed into the prostate to identify a tumour before radiation therapy, allowing the doctor to offer higher radiation doses with comparatively less damage to neighboring healthy tissue. With the rising number of cancer cases worldwide, fiducial markers can play a crucial role in cancer treatment, and that will lead to its market growth. The fiducial markers aid in locating a tumor with higher precision, allowing a treatment team to distribute the extreme dose to neighboring healthy tissue. As of 2022, around 20 million novel cancer cases and 9.7 million deaths were registered and as per the new evaluation of IARC’s Global Cancer Observatory denotes those 10 kinds of cancer collectively consist of 2/3rd of novel cases and deaths. The growing number of cancer cases requires the high involvement of fiducial markers in the global scenario. CIVCO Radiotherapy, IZI Medical Products, Naslund Medical AB, Medtronic PLC, QlRad, Inc. and QFIX are significant companies in the global Fiducial Markers Market.

Analyst’s Observation on Japan Fiducial Markers Market Survey

Fiducial markers are concerned with a guarantee that radiation is distributed to the concerned tumor instead of neighboring healthy tissue. VISICOIL, the first percutaneous fiducial marker permitted for stereotactic body radiotherapy in Japan, and to estimate its clinical & technical efficiency. Since then, quite a lot number of advancements have been made in the fiducial markers’ application. One of them is NOVA, the 1st nonmetallic, MRI-positive signal fiducial marker that considerably minimizes dose perturbation while minimizing artefacts. Such innovation bodes well for the high demand for fiducial markers in the Japanese healthcare market. The increase in the acceptance of radiotherapy as an efficient therapy process, either for primary supervision or symptom regulation is another reason for the growth of the Japanese fiducial markers market. Olympus Corporation is one of the key companies in the Japanese Fiducial Markers Market.

Fiducial Markers Market Growth Driver & Market Restraint

Growth Driver

Availability of various types of fiducial markers:

Convention radiotherapy has experienced massive improvements recently, leading to higher dose conformity by applying intensity-modulated radiation methods, particle therapy with charged ions and image management. The amalgamation of contemporary irradiation imaging and devices, such as X-rays and on-board imaging or alliances with in-machine computed tomography, such as tomotherapy mechanisms have been discovered. Further, a combination of in-room CT scanners and linear accelerators has been articulated; and the clinical execution of raster-scanned ion beam therapy for a wide range of oncologic diseases has been accomplished at the Heidelberg Ion-beam Therapy Center since long (2009). The application of fiducial markers has become a feasible choice to ease the precise distribution of external beam radiation to the treatment area of a patient during IGRT and IMRT treatments.

High success rate of radiotherapy:

The high success rate of radiotherapy propels the fiducial markers market worldwide. Radiation therapy has a 90 to 95% accomplishment rate in Stage 1, an 85-90% accomplishment rate in Stage 2 and a 75-80% accomplishment rate in Stage 3. Distinct methods of radiation therapy are used to handle nasopharyngeal cancers, and they cover IMRT, proton therapy or IGRT. All phases of nasopharyngeal cancer are treated with chemoradiation, with a high success rate. Stage 1 lung cancer is managed with stereotactic body radiotherapy. Managing radiation therapy combined with chemotherapy aids to handle stage II and III lung cancer with a high accomplishment rate. It just not only handles initial-stage lung cancer but even postpones the progression of technically advanced lung cancer. With high success rate, the fiducial markers market can show unprecedented growth in the global market.

Market Restraint

Shortage of skilled professionals:

Healthcare officials need customized training to efficiently apply technically advanced fiduciary markers and a dearth of trained personnel hinders the market growth.

Safety concerns:

Any negative incidence or security concerns associated with fiducial markers result in adverse perceptions and restrain market growth. Fiducial markers are worthy in medical treatment and imaging but have difficulties including threats from probability for marker migration, and threat from placement procedure.

Fiducial Markers Market Segmentation

Our experts at KD Market Insights have segmented the global Fiducial Markers Market research report as:

Fiducial Markers Market Regional Synopsis

North America dominated the Fiducial Markers market due to the high prevalence of fiducial markers market due to the high prevalence of prostrate cancer. Intraprostatic fiducials enable precise prostate positioning guaranteeing RT treatment precision. Placing of gold fiducials are cost efficient marker which is quickly and easily implanted and around 3 fiducials. A high proportion of patients having prostate cancer are treated with the help of external beam radiation therapy. In the United States as of 2021, 236,659 novel prostate cancer cases were registered. CIVCO Medical Solutions in United States is a trusted associate for ultrasound probe covers, disinfection mechanism and probe cleaning, ultrasound needle guides. The medical solution is dedicated to making image guided procedures secure with the help of manufacturing and design of innovative ultrasound projects and radiology. Increasing radiotherapy centres in the United States is expected to encourage market growth, for instance, Alabama’s 1st proton therapy center was inaugurated as on 2018 and the new center is the alliance between the Proton International and the University of Alabama.

Asia Pacific is expected to grow with fastest CAGR due to the increasing proportion of ageing population. The ageing population is more prone to develop cancer and other chronic diseases which needs accurate localization for treatment, thus propelling the market growth of fiducial markers. China’s population is ageing faster in comparison to other countries and it is anticipated that as of 2050, the retirement age will be 39. The increasing investment in healthcare infrastructure is another reason which will push the fiducial markers market in regions such as India and China. The increasing acceptance of stereotactic Body Radiotherapy in standard treatment for the non-small cell lung cancer which is medically inoperable.

Europe has an influential role in the fiducial markers market because region such as France, Germany and Italy top the cancer tests list. As per the rule of the European Society for Radiotherapy and Oncology, respiration correlated 4D-CT imaging for treatment planning is necessary by 50% institutions. Further, government fundings to help cancer research centers to help them employ top quality radiotherapy push the market growth of the fiducial markers market in the region.

Fiducial Markers Market Competitive Landscape

Some of the key players who have the top global Fiducial Markers Market share:

• CIVCO Radiotherapy
• IZI Medical Products
• Naslund Medical AB
• Medtronic PLC
• QlRad, Inc.
• QFIX, Boston Scientific Corp
• Nanovi A/S
• Eckert & Ziegler
• IBA Dosimetry GmbH.
• Horizon Hobby, LLC.

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Air Freshener Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Product
      2. By Cancer Type
      3. By Modality
      4. By End User
      5. By Region
5. Market Segmentation by Product
   1. Metal Based Markers
   2. Polymer Markers
   3. Others Others
6. Market Segmentation by Cancer Type
   1. Therapeutic
   2. Prostate Cancer
   3. Lung Cancer
   4. Breast Cancer
   5. Others
7. Market Segmentation by Modality
   1. CT
   2. CBCT
   3. MRI
   4. Ultrasound
   5. Others
8. Market Segmentation by End User
   1. Hospitals
   2. Outpatient Facilities
   3. Others
9. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User          
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      5. South Korea
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      6. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3.               Market Analysis by Product, Cancer Type, Modality, and End User         
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User          
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product, Cancer Type, Modality, and End User         
10. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
       1. CIVCO Radiotherapy
       2. IZI Medical Products
       3. Naslund Medical AB
       4. Medtronic PLC
       5. QlRad, Inc.
       6. QFIX, Boston Scientific Corp
       7. Nanovi A/S
       8. Eckert & Ziegler
       9. IBA Dosimetry GmbH.
       10. Horizon Hobby, LLC.
       11. Others
11. Strategic Recommendations
12. Appendix
    1. List of Tables
    2. List of Figures
13. References